Answer
It is licensed for selected adults with advanced or metastatic renal cell carcinoma, gastrointestinal stromal tumour after imatinib failure or intolerance, and progressive unresectable or metastatic well-differentiated pancreatic neuroendocrine tumours.
Sources for this answer
- Sunitinib 50 mg hard capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.